Threshold Pharmaceuticals Inc (THLD.O)

THLD.O on Consolidated Issue listed on NASDAQ Capital Market

4.18USD
11 Jul 2014
Price Change (% chg)

$0.06 (+1.46%)
Prev Close
$4.12
Open
$4.09
Day's High
$4.20
Day's Low
$4.07
Volume
227,815
Avg. Vol
417,253
52-wk High
$6.05
52-wk Low
$3.51

THLD.O

Chart for THLD.O

About

Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors and the bone marrows of some hematologic malignancies (blood cancers) as treatments for patients living with cancer. The Company's hypoxia activated prodrug product... (more)

Overall

Beta: 2.41
Market Cap (Mil.): $248.07
Shares Outstanding (Mil.): 59.35
Dividend: --
Yield (%): --

Financials

  THLD.O Industry Sector
P/E (TTM): -- 102.68 35.77
EPS (TTM): -0.55 -- --
ROI: -33.61 -0.70 18.27
ROE: -- -1.57 19.16
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks